SecBot SecBot
DEFA14A ·Filed Apr 21, 2026

RCUS

Arcus Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed6mo ago SEC0001724521-26-000026
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for any follow-up filings related to the recent officer departure or the outcome of the annual meeting vote.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$26.62
T+0 close · Apr 21, 2026 · via day close
Latest settled
+2.82%
T+60 · $27.37
Vs SPY
−1.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 22 $26.62entry
  2. T+1 · 7mo ago −5.60%α −5.20% · $25.13
  3. T+5 · 7mo ago −7.79%α −7.85% · $24.55
  4. T+20 · 6mo ago −14.54%α −17.70% · $22.75
  5. T+60 · 4mo ago +2.82%α −1.96% · $27.37
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Arcus Biosciences, Inc. is holding its 2026 Annual Meeting to vote on director elections, auditor appointment ratification, and executive compensation. This is a routine proxy filing, not a shareholder vote outcome. A recent officer departure filing suggests potential governance issues, but the proxy itself is standard.

Key Financial Metrics

Vote
director election
Meeting
2026-06-11

Key Facts

  • Filing is a DEFA14A, the definitive proxy statement for the 2026 Annual Meeting.
  • Vote items include the election of four directors, ratification of Ernst & Young as auditors, and advisory approval of executive compensation.
  • A recent 8-K filing (March 23, 2026) reported the departure of an officer, which may indicate internal changes.
  • The filing is routine and does not contain material financial information or significant strategic announcements.

Financial Impact

No material financial impact from this filing.

Risk Factors

  • The recent officer departure may indicate potential governance or strategic instability.
  • The outcome of the shareholder vote, while expected to pass, could be influenced by activist sentiment if present.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001724521-26-000026
Document: 0001724521-26-000026-index-headers.html0001724521-26-000026
Document: 0001724521-26-000026-index.html0001724521-26-000026
Document: 0001724521-26-000026.txt0001724521-26-000026

Track record

13 reports on RCUS

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +4.24% at T+1 after the Oct 21, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $16.95 Now $16.86 −0.53% settles Nov 23
  2. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $18.95 to $16.86 Now $16.86 −11.03% ▼ −11.03% −9.34% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $17.69 to $17.77 Now $16.86 −4.69% ▲ +0.45% −2.84% vs SPY
  4. Oct 23, 202624d ago 8-K Bearish 5/10 Entry $17.76 to $18.19 Now $16.86 +5.07% ▼ −2.42% −3.68% vs SPY
  5. Oct 22, 202625d ago 424B5 Bearish 6/10 Entry $18.54 to $18.19 Now $16.86 +9.06% ▲ +1.89% +1.33% vs SPY
  6. Oct 21, 202626d ago 424B5 Bearish 5/10 Entry $19.36 to $18.61 Now $16.86 +12.91% ▲ +3.87% +4.58% vs SPY
  7. Oct 21, 202626d ago 8-K Neutral 4/10 Entry $19.36 to $18.61 Now $16.86 −12.91% ▼ −3.87% −4.58% vs SPY
  8. Oct 20, 202627d ago 8-K Neutral 4/10 Entry $23.75 to $18.14 Now $16.86 −29.01% ▼ −23.62% −23.70% vs SPY
  9. Jul 9, 202618w ago 144 Neutral 3/10 Entry $28.92 to $26.64 Now $16.86 −41.70% ▼ −7.88% −7.32% vs SPY
  10. Apr 21, 202629w ago DEFA14A Neutral 2/10 Viewing Entry $26.62 to $24.55 Now $16.86 −36.66% ▼ −7.79% −7.85% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026